Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amoxicillin trihydrate (substance) |
Is a |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin measurement |
Component |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amoxicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxycillin adverse reaction |
Causative agent (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to amoxicillin (finding) |
Causative agent (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin overdose |
Causative agent (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 125mg/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 125mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 125mg/1.25mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 3g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin (as amoxicillin sodium) 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 250mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral amoxicillin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 875 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 400mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin with clavulanate potassium |
Is a |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium adverse reaction |
Causative agent (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 125mg/31mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 500mg/125mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 400mg/57mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 250mg/125mg s/f dispersible tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 250mg/62.5mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
médicament contenant amoxicilline et acide clavulanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 200mg/28.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 250mg/62.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 400mg/57mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 200mg/28.5mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amoxicillin and clavulanate potassium in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amoxicillin and clavulanate potassium in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 875mg/125mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin trihydrate 200mg tablet disperdose for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin trihydrate 400mg tablet disperdose for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 600mg tablet for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 1g/62.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 200mg/28.5mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin sodium (substance) |
Is a |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 775mg extended release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to amoxicillin (finding) |
Causative agent (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Amoxicillin and clavulanate |
Is a |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 400 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 875 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 875 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-amoxiclav 875mg/125mg tablet (product) |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-amoxiclav 500mg/125mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Co-amoxiclav 500mg/125mg tablet (product) |
Has basis of strength substance (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-amoxiclav 875mg/125mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Co-amoxiclav 875mg/125mg tablet (product) |
Has basis of strength substance (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing amoxicillin and clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin trihydrate (substance) |
Is modification of (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin sodium (substance) |
Is modification of (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin and clavulanate |
Is modification of (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 1g/62.5mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 250mg/125mg tablet for conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 125mg/sachet powder for conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxycillin 3g/sachet powder for conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 500 mg oral tablet |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 400 mg oral tablet |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-amoxiclav 500mg/125mg tablet (product) |
Has precise active ingredient |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-amoxiclav 875mg/125mg tablet (product) |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 875 mg oral tablet |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
Has precise active ingredient |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amoxicillin (as amoxicillin sodium) 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Amoxicillin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |